Cornerstone Wealth Group LLC Invests $232,000 in HCA Healthcare, Inc. $HCA

Cornerstone Wealth Group LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 605 shares of the company’s stock, valued at approximately $232,000.

Several other institutional investors also recently modified their holdings of the business. Brighton Jones LLC bought a new stake in HCA Healthcare during the fourth quarter worth $1,021,000. GAMMA Investing LLC boosted its holdings in shares of HCA Healthcare by 17.6% in the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after buying an additional 737 shares during the last quarter. Sowell Financial Services LLC purchased a new stake in HCA Healthcare during the first quarter worth about $999,000. Grove Bank & Trust grew its position in shares of HCA Healthcare by 14.9% during the 1st quarter. Grove Bank & Trust now owns 833 shares of the company’s stock valued at $288,000 after acquiring an additional 108 shares during the period. Finally, Essex Savings Bank grew its holdings in HCA Healthcare by 8.1% during the first quarter. Essex Savings Bank now owns 855 shares of the company’s stock valued at $295,000 after purchasing an additional 64 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $420.38 on Thursday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $439.01. The company’s fifty day moving average price is $408.25 and its 200-day moving average price is $377.15. The firm has a market capitalization of $98.37 billion, a price-to-earnings ratio of 17.67, a PEG ratio of 1.32 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the prior year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 1.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent research reports. The Goldman Sachs Group started coverage on HCA Healthcare in a research report on Tuesday. They set a “buy” rating and a $470.00 price target on the stock. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a report on Monday, July 28th. Bank of America raised their price target on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Finally, Wells Fargo & Company increased their price objective on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $431.07.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.